HLS Therapeutics (HLS.V) Q2 2025 Earnings

May 8Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.25
-0.21
-0.17
-0.13

Details

Expected EPS
-0.1667401696
Actual EPS
-0.194894
Surprise EPS
-0.03
Surprise Percent
-16.88%

Description

⁨HLS Therapeutics⁩ (⁦HLS.V⁩) has reported earnings of ⁦-0.194894⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts